Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Familial Risk in Patients With Carcinoma of Unknown Primary.
Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Akerley W, Gilcrease G, Ulrich CM, Burt RW, Curtin K. Samadder NJ, et al. Among authors: gilcrease g. JAMA Oncol. 2016 Mar;2(3):340-6. doi: 10.1001/jamaoncol.2015.4265. JAMA Oncol. 2016. PMID: 26863281
Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival.
Lloyd S, Baraghoshi D, Tao R, Garrido-Laguna I, Gilcrease GW 3rd, Whisenant J, Weis JR, Scaife C, Pickron TB, Huang LC, Monroe MM, Abdelaziz S, Fraser AM, Smith KR, Deshmukh V, Newman M, Rowe KG, Snyder J, Samadder NJ, Hashibe M. Lloyd S, et al. Among authors: gilcrease gw 3rd. Am J Clin Oncol. 2019 Apr;42(4):355-362. doi: 10.1097/COC.0000000000000529. Am J Clin Oncol. 2019. PMID: 30844850 Free PMC article.
A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE).
Gumbleton M, Allan S, Conway H, Boucher K, Marvin J, Hawks J, Burnett W, Van Brocklin M, Whisenant J, Gilcrease G, Gupta S. Gumbleton M, et al. Among authors: gilcrease g. BMC Res Notes. 2023 Feb 16;16(1):16. doi: 10.1186/s13104-023-06283-5. BMC Res Notes. 2023. PMID: 36797744 Free PMC article. Clinical Trial.
Discrepancies between tumor genomic profiling and germline genetic testing.
Pauley K, Koptiuch C, Greenberg S, Kohlmann W, Jeter J, Colonna S, Werner T, Kinsey C, Gilcrease G, Weis J, Whisenant J, Florou V, Garrido-Laguna I. Pauley K, et al. Among authors: gilcrease g. ESMO Open. 2022 Aug;7(4):100526. doi: 10.1016/j.esmoop.2022.100526. Epub 2022 Jul 1. ESMO Open. 2022. PMID: 35780590 Free PMC article.
Occult primary, version 3.2014.
Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen WK, Bergman MA, Freedman-Cass DA; National Comprehensive Cancer Network. Ettinger DS, et al. Among authors: gilcrease gw. J Natl Compr Canc Netw. 2014 Jul;12(7):969-74. doi: 10.6004/jnccn.2014.0093. J Natl Compr Canc Netw. 2014. PMID: 24994917
Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer.
Wells SM, Boothe D, Ager BJ, Tao R, Gilcrease GW 3rd, Lloyd S. Wells SM, et al. Among authors: gilcrease gw 3rd. Clin Colorectal Cancer. 2020 Jun;19(2):91-99.e1. doi: 10.1016/j.clcc.2019.11.002. Epub 2020 Mar 12. Clin Colorectal Cancer. 2020. PMID: 32173281
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.
Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW 3rd, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M. Kinsey CG, et al. Among authors: gilcrease gw 3rd. Nat Med. 2019 Apr;25(4):620-627. doi: 10.1038/s41591-019-0367-9. Epub 2019 Mar 4. Nat Med. 2019. PMID: 30833748 Free PMC article.
22 results